DT&CRO Co. Ltd. engages in the research and development of medicine and pharmaceuticals. It provides a full-service series of consignment studies ranging from non-clinical GLP toxicity, PK, and efficacy tests to analysis, livelihood, clinical trials, and licensing consultations required for licensing medicines, chemicals, health-function foods, cosmetics, and medical devices. The company was founded on April 3, 2017 and is headquartered in Yongin-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company